Table 3: Comparisonthe hemogram, iron, TIBC, and ferritin valuesaccording to thenumber of antiglaucomatous agents used in Group 2.

The number of antiglaucomatous agents used
The number of patients
1
(Mean± SD)
n=28
2
(Mean ± SD)
n=31
3
(Mean ± SD)
n=36
4
(Mean ± SD)
n=36
P value

Hb g/dl13.48±1.5012.85±1.9013.45±2.0414.11±1.540.14
Rbc 106/ml4.87±0.554.46±0.455.00 ±1.734.83±0.460.28
Htc %39.66±4.4838.71±5.6739.68±6.4342.11±3.250.16
MCV fl83.69±4.5386.66±6.8488.07±10.2788.04±6.560.34
MCHC g/dl33.25±2.0932.77±1.0032.56±1.7632.87±1.320.65
MCH pg28.40±2.1528.85±2.4029.52±3.8727.48±6.020.69
RDW %13.38±1.3314.02 ±1.6013.72±1.4313.39±1.060.39
Feµg/dl69.69±31.2474.42±32.2575.44±42.6284.00±41.390.71
TDBKµg/dl293.07±65.82284.95±80.11261.22±66.25253.81±52.50.25
Ferritin ng/ml
Median (Min-Max)
69.90
(5-250)
67.46
(3-254)
67.58
(3-238)
70.88
(12-277)
0.93
Plt 103/ml230.77±50.99287.79±85.93257.11±38.90264.67±55.280,07

Hb: hemoglobin; Rbc: red blood cells; Htc: Hematocrit; MCV: mean corpuscular volume; MCHC: mean corpuscular hemoglobin concentration; MCH: mean corpuscular hemoglobin; RDW: red blood cell distribution width; Fe: iron; TIBC: total iron binding capacity; SD: standard deviation; Min: minimum; Max: maximum.